Clinical Trials Administrator Archives – September 1, 2006
September 1, 2006
View Archives Issues
-
Do you know what sponsors want from your site? Experts offer clues
With a rapid acceleration of changes in the clinical trial industry, including international outsourcing, even experienced clinical trial professionals might find it a little confusing trying to figure out what sponsors want from their sites. -
Tackle the beast of study delays following these principles
Study delays continue to accelerate costs of conducting clinical trial research and are a problem for clinical trial sites, as well as sponsors. -
Compliance Corner: Complaints about FDA investigators are on rapid rise, raising concerns
The Food and Drug Administration (FDA) has collected complaints about investigators for decades, but a look at the volume of complaints within the past eight years shows there are major compliance concerns at present. -
Data mining, data warehousing may be relatively new, but here to stay
The use of data mining in the pharmaceutical clinical trial industry might still be in the Triassic era, but that is changing. -
Discussion of microdosing with Xceleron CEO
In this question-and-answer article, R. Colin Garner, BPharm, PhD, DSc, FRCPath, chief executive officer of Xceleron, Ltd. of York, England, discusses how microdosing works, and why it is useful for reducing cost and time in clinical trial work. -
Here's a look at a study of data mining's use in patient care
Data mining provided an ideal approach for predicting survival time for kidney dialysis patients, according to one study.